Zoltero 4mg Injection

About Zoltero 4mg Injection

Zoltero 4mg Injection contains Zoledronic Acid, a bisphosphonate medication used to treat and prevent a variety of bone disorders. It is indicated for the treatment of tumor-induced hypercalcemia (TIH), a condition in which cancer causes abnormally high calcium levels in the blood, and for the prevention of skeletal-related complications in adults with multiple myeloma or bone metastases from solid tumors when used alongside standard cancer therapy. Zoltero 4mg Injection is also prescribed to treat and prevent osteoporosis in postmenopausal women, osteoporosis in men, glucocorticoid-induced osteoporosis, and Paget's disease of bone, helping to strengthen bones, reduce bone loss, and lower the risk of fractures. It works by inhibiting bone resorption, thereby improving bone density and maintaining healthy calcium balance. This medication is administered as an intravenous infusion by a healthcare professional and should not be self-administered. Patients should not use Zoltero 4mg Injection if they are allergic to Zoledronic Acid, other bisphosphonates, or any of its ingredients, or if they are pregnant or breastfeeding. Before starting treatment, patients should inform their doctor about any history of kidney or liver disease, bone disorders, dental problems, jaw pain, swelling, or numbness, as these conditions may require additional monitoring. Zoltero 4mg Injection is not recommended for children and adolescents under 18 years of age. Although it helps manage bone complications associated with cancer, it is not a chemotherapy medication and does not treat or prevent the spread of cancer. Regular monitoring of kidney function, calcium levels, and overall bone health is recommended to ensure safe and effective treatment.